Walsh & Associates’s Johnson & Johnson JNJ Stock Holding History

Walsh & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Sell	1,615 -3	-0.2%	-$699	0.34%	37
2026 Q1	$396K	Buy	1,618 +3	+0.2%	+$699	0.39%	37
2025 Q4	$334K	Buy	+1,615	New	+$319K	0.33%	39

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Walsh & Associates's JNJ Position: Q2 2026 in Review

Walsh & Associates reduced its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, selling an estimated $699 and leaving 1,615 shares worth $410K. The position accounts for 0.34% of the portfolio, ranked #37.

Walsh & Associates first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Walsh & Associates held 1,615 shares of Johnson & Johnson worth $410K as of Q2 2026.
Walsh & Associates sold 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
Johnson & Johnson made up 0.34% of Walsh & Associates's portfolio in Q2 2026, its #37 holding.
Walsh & Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Walsh & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.